< Key Hightlight >

MARKET OUTLOOK

Triton’s report on the non-PVC IV bags market in the Middle East and Africa has determined it to progress with a CAGR of 7.74% over the forecast period from 2021 to 2028. Saudi Arabia, South Africa, Turkey, the United Arab Emirates, and Rest of Middle East & Africa together constitute the market in this region.

In the UAE, the availability of the latest healthcare treatments and technologically advanced solutions is raising the demand for non-PVC IV bags. The nation offers comprehensive health services funded by the government, and a rapidly developing private health sector to deliver a high standard of care to the public. Healthcare is regulated at both the emirate as well as federal levels. 

The development of the healthcare infrastructure in the nation is also influencing the adoption of non-PVC IV bags, as the traditionally-used IV containers may lead to the interaction of drugs & packing materials and difficulty in handling, transporting, & disposing of containers.

Also, the government is taking several initiatives for environmental safety to boost the demand for non-PVC IV bags. For instance, Abu Dhabi has announced plans to ban single-use plastic bags in the emirate. Such a ban on the usage of plastic bags in the country will enhance the demand for non-PVC bags, which will consequently drive the market growth in the United Arab Emirates over the forecast period.

COMPETITIVE OUTLOOK

Polycine GmbH, Huaren Pharmaceutical, Baxter International Inc, Angiplast Pvt Ltd, Otsuka, Fresenius Kabi, Renolit, and ICU Medical are some of the prominent companies present in the non-PVC IV bags market.